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ABSTRACT 
Previous  somatic  treatments  of  schizophrenia  include  continuous  sleep  therapy,  insulin  coma,  electroconvulsive  therapy  & 
psychosurgical treatments. These options are usually associated with serious adverse effects. Over the ensuing 50 years, several 
classes of compounds with anti-psychotic activity have been developed. Fluphenazine is one of the typical antipsychotic drugs, 
use to treat schizophrenia and other mental disorders.  
The present study was designed to evaluate various neuronal damages & behavioral impairment caused by the intramuscular 
administration of fluphenazine deconate in the rats. Rats were treated with 5mg/0.2ml fluphenazine IM for one month. This 
research work revealed a definite pattern, sequence and manifestation of the adverse effects produced by the drug during the 
whole  period.  Fluphenazine  treated  rats  have  shown  a  significant  decreased  loco  motor  activity,  some  neuronal  damage  & 
cognitive impairment, as rats developed rotational behavior & ptosis  after the chronic administration of the drug which  is a clear 
cut indication of neuronal stress as compare to the control rats. The inhibition of the locomotor activity is may be due to decreased 
level of dopamine, GABA ergic hypofunction & oxidative stress at basal ganglia. Cognitive impairment & rotational behavior in 
fluphenazine treated rats clearly revealed that this drug may impart neuronal damage in rats. 
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1. INTRODUCTION 
Antipsychotic agents in the central nervous system have been considered to play an important role in modulation of 
mental diseases. Antipsychotics work by blocking dopamine receptors along with three pathways, and over the long-
term, these pathways become increasingly dysfunctional (at least in a high percentage of patients.) The dysfunction in 
the basal ganglia leads to tardive dyskinesia. The dysfunction in the limbic system and the frontal lobes leads to 
tardive psychosis and tardive dementia.
1 Beside their beneficial effects these drugs shown severe potential side effect 
like neuronal damage, cognitive impairment, impaired loco motor activity, tardive dyskinesia, dystonia and other extra 
pyramidal effects. Various clinical
2,3 and experimental
4 studies have been carried out to study the effects of different 
neuroleptic  drugs  which  are  considered  to  affect  via  neurotransmitter  systems
5.The  clinical  results  about  the 
mechanism of these drugs are continuing up to now
6,7. More recently, investigators have postulated that neuroleptic 
medications may cause effect on motor system through mechanism other than direct dopaminergic receptor blockade. 
There is a possibility that neuroleptic medications may exert an effect on motor system through the creation of free 
radicals
8. The hippocampal region is an essential component of learning and memory processes
9 and has been shown 
to be damaged by a number of toxicants
10,11,12 some of which are neuroleptic agents
13 Previous studies shows that 
fluphenazine has a tendency towards deterioration in the phase of memory consolidation
14. 
Fluphenazine  is  a  phenothiazine  derivative  used  to  treat  schizophrenia  and  mental  disorder;  it  blocks 
postsynaptic  dopamine  receptors  in  the  mesolimbic  system  and  increase  dopamine  turnover  by  blockade  of  DA 
somatodandritic autoreceptor
15. Fluphenazine differs from some phenothiazine derivatives in several aspects: it has 
less potentiating effect on CNS depressants and anesthetics than some of the phenothiazines and appears to be less 
sedating
16.  But  long-term  administration  of  fluphenazine  may  contribute  to  the  drug-induced  antipsychotic  extra 
pyramidal effects
17. 
In the present study we attempted to evaluate the behavioral changes and possible neuronal damage in rats by 
fluphenazine deconate. For this purpose drug was administered for a period of one month and observed different 
behavior of rats by means of experimental parameters.  
 
2. EXPERIMENTAL 
The present study was carried out on 20 locally bred Swiss albino rats weighing from 150– 200 gram. All animals 
were equally divided into 2 groups each comprising of 10 animals, one group was served as control and the second 
group was Fluphenazine deconate treated. The animals were housed in standard sized polypropylene cage in pair and 
are maintained in reserve light and dark cycle of 12 hour. 
Fluphenazine deconate is available as 25mg/ml in ampule form, each rat was given a fixed dose of 0.2ml/day 
containing 5ml of drug intramuscularly, while control animal were given saline daily. All the animals were maintained 
under constant environment condition 21 ± 1°C and humidity (50-60%). 
 
2.1 Experimental parameters 
All parameters were carried out in balanced design to avoid the order effect. Various experimental parameters were Pakistan Journal of Chemistry 2011 
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monitored during 30 days treatment and are given below 
 
2.1.1 Cage Crossing Activity 
Apparatus: Specifically designed Perspex cages (26×26×26cm) with Sawdust covered floor were used to monitor the 
cage crossing activity. 
Procedure: The experiment was conducted in separate quite room. Both control and treated rats were placed in 
separate activity boxes. Rats become familiarized with their environment during this period. Then rats were observed 
for number of cage crossing within 5 minutes. 
 
2.1.2 Open Field Activity 
Apparatus: The open field apparatus used in the present study consisted of a square area (76×76cm) with walls 42cm 
high. The floor of apparatus was divided by lines into 25 squares. 
Procedure: Experiment was conducted in a quiet room and white light. To determine open field activity, an animal is 
taken out from the home cage and was placed for first time in the center of open field apparatus. Number of squares 
crossed with all four paws and latency to move from the center square was scored for 5 minutes. 
 
2.1.3 Traction 
Apparatus: The apparatus consist of especially designed metallic wire / rod in order to monitor the gripping activity 
of rat. 
Procedure: The rat was forced to hang on a wire / rod and the time for which rat hang the wire / rod was noted. 
 
2.1.4 Exploration 
Apparatus: Especially designed box having small holes like windows at a specific distance were used to monitor 
exploratory activity of rats. 
Procedure: Animal was taken out from its home cage and placed in especially designed box. The animal tried to 
escape from these opening and dipped its head through these openings, the number of head dipped was counted for 
each rat for the period of 5 minutes. 
 
2.1.5 Gross behavior 
All the animal were observed for acute behavioral changes of the drug, these include grooming, Straub’s phenomenon, 
Writhing  reflex,  tremors,  twitches,  righthing,  reflex,  pinna  reflect,  corneal  reflex,  anapthalamus,  salivation, 
lacrimation, defecation and urination etc. 
 
3. STATISTICAL ANALYSIS 
Results are presented as mean ± standard. Comparison of difference of mean between control and Fluphenazine 
deconate  treated  group  was  made  by  using  student's  t-test.  P  value  less  than  0.05  were  considered  statistically 
significant and p value less than 0.005 were considered highly significant.  
 
4. RESULTS 
4.1 Effect of fluphenazine deconate on Gross behavior 
Table1. Shows variety of acute gross behavior changes after administration of fluphenazine deconate during 30 days. 
The  result  observed  were tremors,  hind  limb  abduction,  ptosis,  muscle  weakness,  grooming,  rotational behavior, 
flaccid tail and neck and statue position etc. 
Table-1: Observation on Gross Behavior 
Days of administration  Control 
Treated Fluphenazine 
5  10  15  20  25  30 
Parameters               
               
Twitches  Normal  No Change  No Change  -  -  -  - 
Ptosis  -  -  -  -  -  -  - 
Hind paw abduction  -  +++  +++  +++  +++  +++  ++++ 
Flacial Passivity  -  ++  ++  ++  +++  +++  ++++ 
Pinna reflex  -  -  +  +  +  +++  ++++ 
Corneal reflex  -  -  +  +  +  +  ++ 
Exopthalamus  -  -  -  -  -  -  - Najam et al, 2011 
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Anopthalamus  -  -  -  -  -  -  - 
Salivation  -  No Change  No Change  No Change  No Change  No Change  No Change 
Lacrimation  Normal  No Change  No Change  No Change  No Change  No Change  No Change 
Defecation  Normal  No Change  No Change  No Change  No Change  No Change  No Change 
Urination  Normal  No Change  No Change  No Change  No Change  No Change  No Change 
Motor activity  Normal  +  ++  ++  ++  ++  +++ 
Head Rotation  Normal  +++  +++  +++  +++  +++  ++++ 
 
4.2 Effect of Fluphenazine deconate on Cage Crossing and Open Field Activity 
Fig-1. Shows the effects of Fluphenazine deconate on cage crossing & open field activity on rats. Statistical analysis 
by  two-tailed  t-test  revealed  that  fluphenazine  deconate  decreases  both  activities  (P<0.01)  which  were  highly 
significant. 
 
 
Fig-1: Effect of Fluphenazine on Open field & Cage crossing activity 
 
4.3 Effect of Fluphenazine deconate on Traction activity &Exploratory behavior 
Fig-2. Shows the effects of Fluphenazine deconate on traction activity and exploratory behavior on rats. Statistical 
analysis  by  two-tailed  t-test  revealed  that  fluphenazine  deconate  decreases  both  activities  (P<0.05)  which  were 
significant. 
 
 
Fig-2: Effect of Fluphenazine on Traction activity & Exploratory behavior 
 
4.4 Effect of Fluphenazine deconate on Forced swimming activity 
Table-2. Shows the effects of Fluphenazine deconate on forced swimming activity of rats. Statistical analysis by two-
tailed t-test  revealed  that fluphenazine  deconate  decreases  forced  swimming  activity  P<0.05)  which  were  highly 
significant.  
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Table-2: Effect of Fluphenazine on Swimming Induced Activity in Rats 
Drugs  Swimming induced activity 
  Control  143.1 ±3.17 
Fluphenazine deconate  13.8**±2.74 
Values are mean ± S.E (n=10) 
P<0.05* =Significant 
P<0.01** =Highly Significant 
 
5. DISCUSSION 
There  are  lot  of  experimental  studies  about  useful  effect  of  neuroleptic  agents  such  as  neuroprotective  and 
neurogenesis at microscopic level
18but it has been mentioned by only some researcher that treatment with these agents 
have  some  side  effects  such  neurodegeneration  or  neuronal  cell  loss
19in  some  area  of  brain,  for  examples 
hippocampus, striatum, medial prefrontal cortex. 
Our study was limited to only one time point for treatment (30 days). The study was designed to evaluate 
neurochemical and behavioral effect of fluphenazine in rats. In present study, Fig-2 Shows significant decreased motor 
activity  in  an  open  field.  Fluphenazine  treatment  induced  hypo  locomotion  is  mediated  by  nigral  dopaminergic 
dysfunction
20 producing few effects on peripheral movements, grooming, immobility and defecation on open field. It 
was proposed that changes in the activity of the noradrenergic system in the amygaloid cortex may be casually related 
to the changes in the activity of the rats in the open field apparatus and can be related to the effect on adenosine which 
contributes to this effect 
20.  
In the present study, Fluphenazine showed a significant effect in home cage activity as shown in Fig-2. This may be 
due to dopamine inhibitory action. Since hyperactivity is often associated with decreased DA and decreased AC at D2 
levels. This could be related to the fact that dopamine reduces the influence of the indirect pathway and increase the 
action of the direct pathway within the basal ganglia
21. 
Our results indicate that Fluphenazine reduced DA concentration and effect on behavior as we have reported in Table-
1. It was reported by Hatib et al.
22 that there is decreased 5HT, NE and DA in the stratum, olfactory tubercle and 
cerebral  cortex,  with  corresponding  elevated  metabolite  levels  within  24  hours  which  could  be  seen  after  the 
administration of anti-psychotics which is consistent with our findings also. 
Fluphenazine induced orofacial dyskinesia, a syndrome related to nigrostriatal dopamine supersensitivity
23. 
Oxidative stress has also been increased during dopamine metabolism in brain. A number of free radicals are formed 
especially iron free radicals are formed which are quite toxic for neurons and neuronal damage may lead to a state 
similar to the Parkinson disease called pseudo Parkinsonism
24 which is clearly observed during the present study. 
Drug  treated  animals  exhibited  complete  loss  of  exploratory  behavior  and  complete  passivity  in  traction  and 
exploratory activity as Fig # 1 shows these effect, this is due to dopamine which produce significant impairment of 
cognitive function and loss of sedation due to severe sedation caused by fluphenazine. Also this effect could be due to 
decreased conductance of  Na
+ ion  as reported by Xiaoping et al
25.  
There was no increased in struggling time during forced swimming test as we can see in Table-2 that clearly indicates 
the fluphenazine does not increase the desire for survival and has no anti- depressant profile. The antidepressant action 
is  due  to  amine  neurotransmitters  and  according  to  Frank  et  al,
24  the  transporter  proteins  require  to  inactivate 
synaptically released dopamine and serotonin resist adaptation, to long term treatment with noval anti-psychotics that 
effect neurotransmission by these amines.   
There  was  more  salivation  in  experimental  animals  and  the  head  was  uncontrollably  moving  and  very 
significantly hind paw abduction was noted that indicate the extent of neuronal damage. Few rats developed rotational 
behavior  which  is  clear  cut  indication  of  neuronal  stress.  D4  receptors  can  be  unregulated  by  nigrostriatal 
dopaminergic denervation, which suggest that unlike D1 and D2 receptors do not play a pivotal role in rotational 
behavior in rats with unilateral dopaminergic lesions
26. Ptosis was very significant due to neuronal damage.   
Limbic system is also affected probably which is called dopamine rich area and according to
27 there is a 
common role for medial prefrontal cortical D2 and striatolimbic D4 receptors in mediating clinical response of typical 
and atypical anti-psychotics. 
One  or  more animals developed  very  characteristic features  such as they  develop an  externally  imposed 
posture. Catalepsy was significant in fluphenazine treated animals as compared to control groups. 
   
6. CONCLUSION 
Present study was planned to see any neuronal damage produced by the drugs, CPZ like fluphenazine deconate 
produces characteristics symptoms in rats i.e ptosis, muscular weakness, head drop, abused hind limb. Our results are 
in accordance with above findings; different experimental parameters were used to check the activity of rats like cage 
crossing, open field, forced swimming, traction and exploration. Drug treated rats shown a significant decreased Najam et al, 2011 
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locomotor activity in these experimental parameters as compare to the control rats. The main reason of decreased 
locomotor activity is due to the decrease level of dopamine, GABA ergic hypofunction, excite toxicity and oxidative 
stress. It was also found that weight and food intake was significantly decreased after the drug administration. There 
was cognitive impairment and rotational behaviors in rats after the administration of fluphenazine deconate which 
clearly revealed that fluphenazine may produce neuronal damage in rats. In clinical settings, should be avoided from 
high dose fluphenazine treatment. 
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